Patent Wars: Who Owns the Rights to Minor Cannabinoids in the Carolinas?

The competition for controlling minor cannabinoids is becoming a legal fight all over the states of North Carolina and South Carolina. With the commercial value of compounds such as THCV, CBG, and THCP rising, the companies are hurrying to get patents on their extraction methods, their unique product designs, and even the synthetic ways of obtaining these compounds under their control. 

Besides, the change of rules about hemp production is making a difference as to what can be legally done and protected. Therefore, the rapid "patent war" happening now may be the one to set the regional cannabis industry's future in motion.

The Rise of Minor Cannabinoids

Minor cannabinoids are a type of chemical compound that exists in very low levels in the cannabis plant. They are different from the major cannabinoids, which include CBD and THC. Some examples of minor cannabinoids are THCV, CBG, CBC, and the recently discovered THCP. 

Their value comes from three main factors:

• Unique effects (e.g., THCV’s appetite-suppressing properties)

• Pharmaceutical potential

• Higher profit margins due to scarcity

Patent activities have mirrored this pattern. On a worldwide scale, patent filings concerning minor cannabinoids rose very fast, almost reaching 39% of total cannabinoid-related filings in 2021 and then maintaining the level.

Why Patents Matter in Cannabis

Now let’s look at the business side. In general, cannabis patents do not cover the plant. They would rather concentrate on the making, processing, and consumption of cannabinoids. This encompasses extraction techniques, production in the laboratory (synthetic), product lines such as beverages or vapes, and medical formulations. For example, some patents already cover certain methods of generating cannabinoids such as CBD, THCV, and CBG in large quantities.

It implies that numerous companies will be able to sell a similar kind of cannabinoid, yet only a small number of them will be permitted to employ some of the methods that are patented to produce them. Due to this, the possession of patents and intellectual property becomes a good strength in the market.

The Carolinas: A Unique Legal Landscape

We must first understand the legal environment that is shaping the patent war before even discussing the patent war.

North Carolina: The “Wild West” of Hemp

North Carolina has become one of the most loosely regulated hemp markets in the U.S., with psychoactive hemp-derived cannabinoids like delta-8 and THCA being widely available in products. Legally, hemp must contain 0.3% or lower delta-9 THC in order to be federally compliant. 

Since there have hardly been any regulations, the market has expanded rapidly. Currently, lawmakers want to introduce new regulations for these products. However, this kind of regulatory environment has allowed businesses to play around with little-known cannabinoids and get their patents approved very quickly.

South Carolina: Moving Toward Regulation

South Carolina is making changes in a measured way when it comes to hemp and cannabis. The newest laws are designed to control hemp-derived cannabinoids by establishing licensing requirements, enforcing product testing, and the introduction of definitive rules for sales and labeling. 

The state is also thinking about cannabis reforms on a bigger scale, a medical program being one of the possibilities. Thanks to these tighter regulations, the market is more orderly, and this is something that can help companies to secure and carry out patent rights.

Where the Patent Wars Are Happening

Now, let us turn to the main question: Who is the legal owner of these cannabinoids?

The answer is not simple since patents are being filed in three major areas.

1. Extraction Technologies 

Companies are in a contest to patent better methods of extracting rare cannabinoids out of hemp. They aim at achieving better yields, reduced costs, and maintaining the purity of the final product. Since these minor cannabinoids are present in very low concentrations, an efficient extraction process is a requirement, and that is why these methods are worth patenting.

2. Synthetic and Semi-Synthetic Production

Competition is even more intense here. Numerous minor cannabinoids are no longer extracted directly by the plant but rather converted into them by a chemical process. Companies are patenting approaches to convert CBD to compounds such as delta-8, THCV, or THCP in addition to making stable synthetic forms and producing at commercial scales. It is increasingly difficult to enter the market and be a free player, as many of these chemical processes are already patented.

3. Formulations and End Products

Patents for cannabis-infused beverages, vaping formulas, and pharmaceutical applications are among the products companies are rushing to patent in the wake of cannabis legalization. Often these so-called cannabis-related patents cover similar things and therefore cause conflicts regarding who has the rights and ownership of them.

The Role of Federal Law in the Conflict

There will be a great transformation with the 2026 federal reinterpretation of hemp, and it may result in the prohibition of many psychoactive hemp-derived cannabinoids. This has two major effects. On one hand, companies are hurrying to get their patents filed before these tougher rules are implemented. On the other hand, the stakes are raised, because if some cannabinoids are declared illegal, the patents associated with them might become worthless. 

So, this new uncertainty is leading companies to adopt bolder IP strategies and be open to taking risks with their intellectual property strategies.

Who Are the Key Players?

Now let’s look at who is actually competing in this space.

• Biotech and Pharmaceutical Firms

• Hemp Processors and Startups

• Universities and Research Institutions

Legal Challenges and Gray Areas

Before we conclude, we should mention the greatest difficulties of these patent battles.

Overlapping Patents

Mostly, many companies claim the same or very similar processes or compounds, which eventually results in disputes between them.

Natural vs Synthetic Debate

Whether or not naturally occurring cannabinoids are eligible for patent protection is still being debated. Generally, products that are found in nature are not patentable. Nevertheless, altered or artificially created (synthetic) versions can be patented, and this is mostly where companies put their efforts.

Enforcement Difficulties

Although a company may have a patent, it is not easy to enforce the patent because of:

• State-by-state legal differences

• Rapidly changing regulations

• Informality of certain hemp markets.

What This Means for the Industry

The future of the Carolinas' cannabis industry is determined by patent wars of minor cannabinoids in three major ways:

• Consolidation: Bigger companies can take over due to robust IP portfolios.

• Innovation: Competition is fostering high rates of technology.

• Pressure of regulation: Governments are intervening to regulate a disorderly market.

Conclusion 

The race for patents on minor cannabinoids in the Carolinas is only beginning, yet the competition is very intense already. Companies are swiftly attempting to get their hands on the control of extraction methods, lab-synthesized processes, and product recipes even as they face complex and confusing laws. The companies that succeed in these patent wars would most likely be the ones who decide the evolution of the cannabis industry in the region for the next decade, considering the potential changes at the federal level and more strict regulations in the states.